Inipharm
Latest round
- Series A
Last raised
- Nov 2020
Total raised
- $35M
Investors
- 4
About Inipharm
Inipharm, Inc.Founded in 2018 and headquartered in Bellevue, US, Inipharm, Inc. operates as a stand-alone entity without any subsidiaries. The company was established with a focus on addressing unmet medical needs in liver disease treatment.Inipharm is a clinical-stage biopharmaceutical company specializing in the development of small-molecule therapies targeting severe liver diseases. Its lead product, INI-822, is currently undergoing Phase 1 clinical trials for metabolic dysfunction-associated steatotic liver disease (MASH). This first-in-class small molecule inhibitor aims to mitigate the progression of fibrotic liver diseases by altering lipid metabolism and improving liver enzyme levels.Inipharm's revenue model focuses on partnerships and collaborations in the biopharmaceutical sector. The company engages in B2B transactions, collaborating with research institutions and clinical trial organizations. Partnerships may include licensing agreements with larger pharmaceutical firms, utilizing their distribution and commercialization capabilities. Financial arrangements typically involve milestone payments based on clinical development progress and potential royalties from future product sales.00 mn to support the advancement of its lead product, INI-822, through ongoing clinical trials and the exploration of strategic partnerships for further development. The company is targeting expansion into additional markets in Europe and Asia by 2023, aiming to enhance its reach within the hepatology field. Additionally, Inipharm is focused on introducing new therapeutics that address other liver-related conditions, reinforcing its commitment to addressing critical healthcare needs.
Who invested in Inipharm
4 investors across 1 round
See all investors in Inipharm
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 11, 2020
Amount
$35M
Investors
Questions about Inipharm
Who invested in Inipharm?
Inipharm has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Inipharm raised?
Inipharm has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Inipharm last raise money?
Inipharm's most recent round on record is a Series A, in Nov 2020.
What does Inipharm do?
Inipharm is a biotechnology company.
Where is Inipharm headquartered?
Inipharm is headquartered in Bellevue, US.
Which VCs invest in companies like Inipharm?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Inipharm's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Inipharm? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.